EF
Therapeutic Areas
Tarsier Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TRS01 | Non‑infectious anterior uveitis (including uveitic glaucoma) | Phase 2 |
| Tarsier-04 | Inflammatory ocular disease (specific indication undisclosed) | Phase 3 |
| Drug | Indication | Phase |
|---|---|---|
| TRS01 | Non‑infectious anterior uveitis (including uveitic glaucoma) | Phase 2 |
| Tarsier-04 | Inflammatory ocular disease (specific indication undisclosed) | Phase 3 |